333 related articles for article (PubMed ID: 11798060)
1. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
[TBL] [Abstract][Full Text] [Related]
2. Racial/Ethnic composition of study participants in FDA-approved oncology new molecular entities, 2006-2008.
Merenda C
J Natl Med Assoc; 2012; 104(9-10):430-5. PubMed ID: 23342816
[TBL] [Abstract][Full Text] [Related]
3. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
Lolic M; Araojo R; Okeke M; Temple R
J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
[TBL] [Abstract][Full Text] [Related]
4. Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA From 2010 to 2012.
Eshera N; Itana H; Zhang L; Soon G; Fadiran EO
Am J Ther; 2015; 22(6):435-55. PubMed ID: 25621972
[TBL] [Abstract][Full Text] [Related]
5. Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.
Chen A; Wright H; Itana H; Elahi M; Igun A; Soon G; Pariser AR; Fadiran EO
J Womens Health (Larchmt); 2018 Apr; 27(4):418-429. PubMed ID: 29048983
[TBL] [Abstract][Full Text] [Related]
6. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
7. Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards.
Eckstein L
Food Drug Law J; 2011; 66(2):243-63, ii-iii. PubMed ID: 24505842
[TBL] [Abstract][Full Text] [Related]
8. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
[TBL] [Abstract][Full Text] [Related]
9. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002.
Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA
J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271
[TBL] [Abstract][Full Text] [Related]
10. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
11. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
Trials; 2016 Apr; 17():199. PubMed ID: 27079511
[TBL] [Abstract][Full Text] [Related]
12. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
13. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.
Sullivan PS; McNaghten AD; Begley E; Hutchinson A; Cargill VA
J Natl Med Assoc; 2007 Mar; 99(3):242-50. PubMed ID: 17393948
[TBL] [Abstract][Full Text] [Related]
14. Progress in improving mental health services for racial-ethnic minority groups: a ten-year perspective.
Santiago CD; Miranda J
Psychiatr Serv; 2014 Feb; 65(2):180-5. PubMed ID: 24178249
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in drug disposition and response: review of recently approved drugs.
Ramamoorthy A; Pacanowski MA; Bull J; Zhang L
Clin Pharmacol Ther; 2015 Mar; 97(3):263-73. PubMed ID: 25669658
[TBL] [Abstract][Full Text] [Related]
16. Influence of race or ethnicity on pharmacokinetics of drugs.
Johnson JA
J Pharm Sci; 1997 Dec; 86(12):1328-33. PubMed ID: 9423140
[TBL] [Abstract][Full Text] [Related]
17. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009.
Hirano SA; Murray SB; Harvey VM
Pediatr Dermatol; 2012; 29(6):749-55. PubMed ID: 23017105
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
19. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
[TBL] [Abstract][Full Text] [Related]
20. Race and Ethnicity in the Evidence for Integrating Palliative Care Into Oncology.
Pirl WF; Saez-Flores E; Schlumbrecht M; Nipp R; Traeger LN; Kobetz E
J Oncol Pract; 2018 Jun; 14(6):e346-e356. PubMed ID: 29813013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
